$50,000 of GLOBAL MEDICAL RESPONSE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to payment for Medicare ambulance services and modernizing the payment system. Issues related to access to ambulance services in Medicaid. Issues related to access to ambulance services related to a natural or other disaster."
You can find more data on corporate lobbying on Quiver Quantitative.
GMRE Insider Trading Activity
GMRE insiders have traded $GMRE stock on the open market 8 times in the past 6 months. Of those trades, 7 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GMRE stock by insiders over the last 6 months:
- MARK OKEY JR DECKER (CEO and President) has made 5 purchases buying 50,894 shares for an estimated $862,738 and 0 sales.
- JAMIE ALLEN BARBER (General Counsel and Secretary) sold 130,000 shares for an estimated $861,068
- ROBERT J KIERNAN (CFO and Treasurer) purchased 3,000 shares for an estimated $95,730
- MATTHEW CYPHER purchased 1,350 shares for an estimated $9,960
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GMRE Hedge Fund Activity
We have seen 77 institutional investors add shares of GMRE stock to their portfolio, and 109 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 1,281,418 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,196,600
- BLACKROCK, INC. removed 1,149,069 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $38,735,115
- STATE STREET CORP removed 405,508 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $13,669,674
- GEODE CAPITAL MANAGEMENT, LLC removed 349,760 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,790,409
- INVESCO LTD. removed 303,734 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,238,873
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. removed 302,991 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,213,826
- ALYESKA INVESTMENT GROUP, L.P. added 296,549 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,996,666
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GMRE Analyst Ratings
Wall Street analysts have issued reports on $GMRE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 10/13/2025
To track analyst ratings and price targets for GMRE, check out Quiver Quantitative's $GMRE forecast page.
GMRE Price Targets
Multiple analysts have issued price targets for $GMRE recently. We have seen 2 analysts offer price targets for $GMRE in the last 6 months, with a median target of $40.5.
Here are some recent targets:
- Amanda Sweitzer from Baird set a target price of $41.0 on 11/11/2025
- Aaron Hecht from JMP Securities set a target price of $40.0 on 10/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
